Skip to Main Content

Author Details

Ghassan Allo
Henry Ford Hospital
2011
25
18
PMIDPaper TitleJournal TitlePublished Year
36906704Comparison of methanol fixation versus cryopreservation of the placenta for metabolomics analysis.Sci Rep2023
37525355The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma.Am J Clin Oncol2023
35326656Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo.Cancers (Basel)2022
34055677Prenatal IgE as a Risk Factor for the Development of Childhood Neurodevelopmental Disorders.Front Pediatr2021
31274700HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.Int J Gynecol Pathol2020
29449057Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy.Clin Oncol (R Coll Radiol)2018
27683181Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.Clin Cancer Res2017
28545687Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer.Gynecol Oncol2017
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
27116183Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.Breast Cancer Res Treat2016
26200271Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.J Thorac Oncol2015
26124487Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.J Clin Oncol2015
23887303ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.Mod Pathol2014
25173583Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.Gynecol Oncol2014
24419422PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.J Thorac Oncol2014
24495259Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.Histopathology2014
24251405Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.Histopathology2014
22899400Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.J Pathol2013
23672928Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199).Gynecol Oncol2013
23715501miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.Carcinogenesis2013
21300463Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers.Int J Radiat Oncol Biol Phys2012
22301492Use of mismatch repair immunohistochemistry and microsatellite instability testing: exploring Canadian practices.Am J Surg Pathol2012
22567578Noninvasive in vivo structural and vascular imaging of human oral tissues with spectral domain optical coherence tomography.Biomed Opt Express2012
23018216Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.Int J Gynecol Pathol2012
25984172Is thrombotic microangiopathy a paraneoplastic phenomenon? Case report and review of the literature.NDT Plus2011
  • 1 - 25 of 25

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 2
Tayyebeh M Nazeran
University of British Columbia
Career Start Year 2016
Number of shared co-authors 9
Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Career Start Year 2016
Number of shared co-authors 12
Philipp Jurmeister
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 0
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 7
Amy Lum
University of British Columbia
Career Start Year 2014
Number of shared co-authors 11
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 8
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2009
Number of shared co-authors 9
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 7
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2007
Number of shared co-authors 9
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 11
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 9
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 9
Joerg Schwock
University of Toronto
Career Start Year 2003
Number of shared co-authors 15
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 0
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 5
Martin K??bel
University of Calgary
Career Start Year 2001
Number of shared co-authors 13
Douglas A Levine
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 14
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 5
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 2
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 15
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 1
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 9
Blaise A Clarke
University of Toronto.
Co-authored papers 7
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Aaron Pollett
Mount Sinai Hospital
Co-authored papers 4
Cyril B Gilks
University of British Columbia
Co-authored papers 3
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers 3
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 3
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Co-authored papers 3
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Co-authored papers 3
Steve E Kalloger
University of British Columbia
Co-authored papers 3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers 3
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 3
Lucia Kim
Inha University Hospital
Co-authored papers 2
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 2
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 2
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 2
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 2
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Stephen Welch
Victoria Hospital
Co-authored papers 2
Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers 2
Christine To
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Michelle R Downes
University of Toronto
Co-authored papers 1
Dan Strumpf
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Nadeem Moghal
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Boris Winterhoff
University of Minnesota
Co-authored papers 1
Michael R Johnston
Dalhousie University
Co-authored papers 1
Release 1.2